glp-1 examples for Weight Loss and Diabetes GLP-1 Support System Sample Pack

In fact, I'm releasing this letter a little earlier than planned because, just yesterday, a series of major headlines dropped reporting that pharmaceutical stocks surged after this next-generation weight-loss drug posted record-breaking results, with participants losing 28.3% of their body weight over 80 weeks

Although weight-loss specific drugs are now licensed, supply is limited, and as a consequence, off-label prescribing of diabetic drugs has continued to grow (particularly of Ozempic (active ingredient: semaglutide) and Mounjaro (active ingredient: tirzepatide))

Medical costs keep going up

Your choice depends on needle comfort, lifestyle demands, and whether you prioritize cost savings or prefer the convenience of daily oral dosing without injections

The oral GLP-1 market is driven by the rising prevalence of type 2 diabetes and obesity, increasing demand for convenient oral treatments, and growing awareness of effective diabetes management options